Northwestern Medicine scientists have recently discovered that two common genetic risk factors for Parkinson’s disease can be regulated with LRRK2 kinase inhibition or GCase enzyme activation, revealing potential for the development of new therapeutics.
Yearly Archives: 2020
Using mathematical modeling and optical imaging they developed themselves, a Northwestern University research team has discovered how chromatin folds at the single-cell level.
People who carry genetic mutations associated with an increased risk for Parkinson’s disease may exhibit minor symptoms long before the disease progresses to affect daily life, according to a study of over 300 patients.
Scientists have discovered a set of neural “conversations” underlying individual neurons’ activity during learned movements, findings with implications for the development of neuroprostheses.
According to a recent study, elevated ocular pressure in glaucoma is generated in the wall of a small vessel in the eye, the Schlemm’s canal.
A Northwestern Medicine study found that episodic memory may be improved through the use of noninvasive transcranial magnetic stimulation of the posterior medial network in the hippocampus.
A new Northwestern University study has discovered that the packing of the three-dimensional genome structure, called chromatin, controls how cells respond to stress.
Northwestern Medicine scientists discovered a clever evolutionary quirk in multi-ciliated cells, which help drive fluid flow in a variety of body systems.
Feinberg has had an exceptional year in 2019, from scientific advances to the development of breakthrough therapies and treatment strategies, as well as continued excellence in educating the next generation of medical leaders.
Cara J. Gottardi, PhD, has been appointed director of the Walter S. and Lucienne Driskill Graduate Program in Life Sciences.